Medisys Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.25 Cr
as on 16-12-2024
- Paid Up Capital ₹ 5.00 Cr
as on 16-12-2024
- Company Age 19 Year, 17 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.20 Cr
as on 16-12-2024
- Satisfied Charges ₹ 2.00 Cr
as on 16-12-2024
- Revenue -45.17%
(FY 2021)
- Profit 82.64%
(FY 2021)
- Ebitda 112.62%
(FY 2021)
- Net Worth -12.50%
(FY 2021)
- Total Assets -9.39%
(FY 2021)
About Medisys Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.25 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹7.20 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Srivastava, Sundeepkumar Khemka, Joel Kurian, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231HP2005PTC030915
- Company No.
030915
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medisys Biotech Private Limited offer?
Medisys Biotech Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Antifungal Injection, Tablet & Syrup, Itraconazole Capsule and Tablet, API (Active Pharmaceutical Ingredients), Pharmaceutical Pellets, Allopathic Cough Syrup, Guaiphenesin Cough Syrup, Weight Loss Supplement, Pharma Ingredients & Raw Materials.
Who are the key members and board of directors at Medisys Biotech?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Srivastava  | Director | 07-Dec-2005 | Current |
| Sundeepkumar Khemka | Director | 01-Oct-2023 | Current |
| Joel Kurian | Director | 25-Jan-2007 | Current |
Rahul Sharma  | Director | 07-Dec-2005 | Current |
| Mohan Ettyreddy | Director | 04-Oct-2017 | Current |
Financial Performance of Medisys Biotech.
Medisys Biotech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 45.17% decrease. The company also saw a substantial improvement in profitability, with a 82.64% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medisys Biotech?
In 2021, Medisys Biotech had a promoter holding of 47.88% and a public holding of 52.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medisys Universal Private LimitedActive 9 years 3 monthsAshok Srivastava, Rahul Sharma and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Oct 2020 | ₹9.90 M | Open |
Others Creation Date: 13 Oct 2016 | ₹0.40 M | Open |
General Manager Creation Date: 16 Feb 2009 | ₹3.00 M | Open |
How Many Employees Work at Medisys Biotech?
Medisys Biotech has a workforce of 30 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medisys Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medisys Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
